Home › Myelofibrosis › California › Irvine
Myelofibrosis clinical trials in Irvine, CA
6 studies for Myelofibrosis are looking for participants at sites in and around Irvine (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- City of Hope-Lennar Foundation Cancer Center, Irvine
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
RecruitingPhase 1
- Site US25, Irvine
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RecruitingPhase 1/2
- City of Hope - Lennar, Irvine
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
RecruitingPhase 1/2
- University of California, Irvine, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Irvine
Myelofibrosis trials in other cities
- New York City, NY21 studies
- Houston, TX20 studies
- Boston, MA13 studies
- Durham, NC13 studies
- Columbus, OH12 studies
- Seattle, WA12 studies
- Tampa, FL11 studies
- Nashville, TN11 studies
- Miami, FL11 studies
- Salt Lake City, UT11 studies
- Ann Arbor, MI10 studies
- Atlanta, GA10 studies
Other studies in Irvine
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer23 studies
- Cancer (all types)18 studies
- Metastatic Cancer16 studies
- Lung Cancer15 studies
- Ovarian Cancer14 studies
- Prostate Cancer14 studies
- Multiple Myeloma14 studies
- Alzheimer's Disease12 studies
- Head and Neck Squamous Cell Carcinoma11 studies
- Bladder Cancer11 studies
- Colorectal Cancer11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.